A coding variant in NLRP1 is associated with autoimmune Addison's disease

Human Immunology

Volumn 71, Issue 5, 2010, Pages 530-534

  Zurawek, Magdalena ^a   Fichna, Marta ^a,b   Januszkiewicz Lewandowska, Danuta ^a,b   Gryczyńska, Maria ^b   Fichna, Piotr ^b   Nowak, Jerzy ^a  

^a INSTITUTE OF HUMAN GENETICS   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Addison's disease; Autoimmunity; NLRP1; Polymorphism

Indexed keywords

NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PROTEIN NLRP1; UNCLASSIFIED DRUG;

ADDISON DISEASE; ADULT; ARTICLE; AUTOIMMUNE ADDISON DISEASE; AUTOIMMUNE DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLAND; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADDISON DISEASE; ADULT; APOPTOSIS REGULATORY PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL;

EID: 77951938522     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.02.004     Document Type: Article

References (25)

1. Erichsen M.M., Lovas K., Fougner K.J., Svartberg J., Hauge E.R., Bollerslev J., et al. Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol 2009, 160:233-237.
2. Betterle C., Dal Pra C., Mantero F., Zanchetta R. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: Autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 2002, 23:327-364.
3. Neufeld M., Blizzard R.M. Polyglandular autoimmune diseases. Symposium on autoimmune aspects of endocrine disorders 1980, Academic Press, New York, NY. A. Pinchera, D. Doniach, G.F. Fenzi, L. Baschieri (Eds.).
4. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., et al. Positional cloning of the APECED gene. Nat Genet 1997, 17:393-398.
5. Pearce S.H.S., Merriman T.R. Genetic progress towards the molecular basis of autoimmunity. Trends Mol Med 2006, 12:90-98.
6. Nejentsev S., Howson J.M.M., Walker N.M., Szeszko J., Field S.F., Stevens H.E., et al. Localizationof type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007, 450:887-892.
7. Vaidya B., Pearce S.H.S. The emerging role of the CTLA4 gene in autoimmune endocrinopathies. Eur J Endocrinol 2004, 150:619-626.
8. Mustelin T., Vang T., Bottini N. Protein tyrosine phosphatases and the immune response. Nat Rev Immunol 2005, 5:43-57.
9. Jin Y., Mailloux C.M., Gowan K., Riccardi S.L., LaBerge G., Bennett D.C., et al. NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007, 356:1216-1225.
10. Martinon F., Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005, 26:447-454.
11. Tschopp J., Martinon F., Burns K. NALPs: A novel protein family involved in inflammation. Nat Rev Mol Cell Biol 2003, 4:95-104.
12. Faustin B., Lartigue L., Bruey J.M., Luciano F., Sergienko E., Bailly-Maitre B., et al. Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell 2007, 25:713-724.
13. Ting J.P., Davis B.K. CATERPILLER: A novel gene family important in immunity, cell death, and diseases. Annu Rev Immunol 2005, 23:387-414.
14. Jin Y., Birlea S.A., Fain P.R., Spritz R.A. Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 2007, 127:2558-2562.
15. Magitta N.F.Bøe Wolff A.S., Johansson S., Skinningsrud B., Lie B.A., Myhr K.M., et al. A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun 2009, 10:120-124.
16. Roycroft M., Fichna M., McDonald D., Owen K., Zurawek M., Gryczyńska M., et al. The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22) gene predisposes to autoimmune Addison's disease. Clin Endocrinol (Oxf) 2009, 70:358-362.
17. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
18. Hastie T., Tibshirani R., Friedman J. The elements of statistical learning. Data mining, inference, and prediction 2001, Springer-Verlag, Canada.
19. Lin P.I., Vance J.M., Pericak-Vance M.A., Martin E.R. No gene is an island: The flip-flop phenomenon. Am J Hum Genet 2007, 80:531-538.
20. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004, 74:765-769.
21. Li J., Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005, 95:221-227.
22. Maclaren N.K., Riley W.J. Inherited susceptibility to autoimmune Addison's disease is linked to human leukocyte antigens-DR3 and/or DR4, except when associated with type I autoimmune polyglandular syndrome. J Clin Endocrinol Metab 1986, 62:455-459.
23. Vaidya B., Imrie H., Geatch D.R., Perros P., Ball S.G., Baylis P.H., et al. Association analysis of the cytotoxic T lymphocyte antigen-4 (CTLA-4) and autoimmune regulator-1 (AIRE-1) genes in sporadic autoimmune Addison's disease. J Clin Endocrinol Metab 2000, 85:688-691.
24. Blomhoff A., Lie B.A., Myhre A.G., Kemp E.H., Weetman A.P., Akselsen H.E., et al. Polymorphisms in the cytotoxic T lymphocyte antigen-4 gene region confer susceptibility to Addison's disease. J Clin Endocrinol Metab 2004, 89:3474-3476.
25. Skinningsrud B., Husebye E.S., Gervin K., Løvås K., Blomhoff A., Wolff A.B., et al. Mutation screening of PTPN22: Association of the 1858T-allele with Addison's disease. Eur J Hum Genet 2008, 16:977-982.